E. Salvador

Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis.

T. Lupia, G. di Perri, A. de Nicolò, 2020, Journal of infection and public health.

Perinatal outcomes of pregnancies resulting from assisted reproduction technology in SARS-CoV-2-infected women: a prospective observational study

Adrian M. Garcia, M. T. González, Raquel G. Seoane, 2021, Fertility and Sterility.

Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV

G. Marchetti, G. di Perri, A. Calcagno, 2022, British journal of clinical pharmacology.

Early Low-Molecular-Weight Heparin Administration is Associated with Shorter Time to SARS-CoV-2 Swab Negativity

A. Calcagno, I. Motta, V. Ghisetti, 2020, Antiviral Therapy.

Antiviral therapy in patients with HBV treated for tuberculosis: a forgotten issue.

T. Lupia, G. di Perri, F. Lipani, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Anti-Xa monitoring improves low-molecular-weight heparin effectiveness in patients with SARS-CoV-2 infection

D. Roccatello, S. Sciascia, G. di Perri, 2020, Thrombosis Research.

Three years prospective clinical and radiologic follow-up of laparoscopic sacrocolpoperineopexy.

J. Grau, J. G. Moreno, E. Salvador, 2020 .